Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Xtant Medical Holdings ( (XTNT) ).
On December 1, 2025, Xtant Medical Holdings sold certain assets tied to its Coflex and CoFix products, along with all outstanding shares of its international hardware subsidiary Paradigm Spine GmbH, to Companion Spine for an initial aggregate purchase price of $19.2 million, partly funded through an unsecured $8.2 million promissory note. On February 27, 2026, Companion Spine paid Xtant $10.7 million to fully repay the note, accrued interest, and purchase price adjustments, increasing total divestiture proceeds to $21.4 million, and Xtant used $2.8 million of this to prepay a portion of its MidCap Financial Trust term loan, reducing the outstanding principal to $11.1 million and strengthening its balance sheet.
The divestitures and subsequent payment materially boost Xtant’s liquidity and provide additional flexibility to reduce debt and reallocate capital toward its remaining operations. By exiting certain product lines and its non-U.S. hardware business, the company sharpens its strategic focus while lowering leverage, which may improve its financial profile and potentially its standing with lenders and investors.
The most recent analyst rating on (XTNT) stock is a Buy with a $0.68 price target. To see the full list of analyst forecasts on Xtant Medical Holdings stock, see the XTNT Stock Forecast page.
Spark’s Take on XTNT Stock
According to Spark, TipRanks’ AI Analyst, XTNT is a Neutral.
Xtant Medical Holdings shows a positive outlook with strong revenue growth and operational improvements, as highlighted in the earnings call. Technical indicators support a bullish trend. However, high valuation metrics and ongoing profitability challenges temper the overall score.
To see Spark’s full report on XTNT stock, click here.
More about Xtant Medical Holdings
Xtant Medical Holdings, Inc. operates in the medical device industry, focusing on spinal technologies and related hardware products. The company has conducted business both within and outside the United States, including through its former wholly owned subsidiary Paradigm Spine GmbH, which managed its hardware operations in international markets.
Average Trading Volume: 184,158
Technical Sentiment Signal: Strong Sell
Current Market Cap: $79.84M
Find detailed analytics on XTNT stock on TipRanks’ Stock Analysis page.